Short answer
Protara Therapeutics, Inc. (TARA) filed an 8-K current report with the SEC on June 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All three Class III nominees elected through 2029, with Cynthia Smith receiving the weakest support at 22.4M votes.
Protara Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All three Class III nominees elected through 2029, with Cynthia Smith receiving the weakest support at 22.4M votes
- Ernst & Young ratified as independent auditor for fiscal 2026 by 45.0M votes, supporting audit continuity
- Say-on-pay approved, with 26.8M votes favoring annual compensation votes
- Equity plan amendment approved by 18.1M votes, enabling expanded employee equity capacity
- Authorized common shares doubled from 100M to 200M, increasing financing flexibility but potential dilution capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Protara Therapeutics, Inc. 8-K filings
Get the next TARA 8-K as it lands
Follow TARA for push alerts, or ask the research agent what this filing means.